Cargando…

Value of Radiodensity Determined by Enhanced Computed Tomography for the Differential Diagnosis of Lung Masses

BACKGROUND: Lung masses are often difficult to differentiate when their clinical symptoms and shapes or densities on computed tomography (CT) images are similar. However, with different pathological contents, they may appear differently on plain and enhanced CT. OBJECTIVES: To determine the value of...

Descripción completa

Detalles Bibliográficos
Autor principal: Xie, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522332/
https://www.ncbi.nlm.nih.gov/pubmed/23329931
http://dx.doi.org/10.5812/kmp.iranjradiol.17351065.3128
Descripción
Sumario:BACKGROUND: Lung masses are often difficult to differentiate when their clinical symptoms and shapes or densities on computed tomography (CT) images are similar. However, with different pathological contents, they may appear differently on plain and enhanced CT. OBJECTIVES: To determine the value of enhanced CT for the differential diagnosis of lung masses based on the differences in radiodensity with and without enhancement. PATIENTS AND METHODS: Thirty-six patients with lung cancer, 36 with pulmonary tuberculosis (TB) and 10 with inflammatory lung pseudotumors diagnosed by CT and confirmed by pathology in our hospital were selected. The mean ± SD radiodensities of lung masses in the three groups of patients were calculated based on the results of plain and enhanced CT. RESULTS: There were no significant differences in the radiodensities of the masses detected by plain CT among patients with inflammatory lung pseudotumors, TB and lung cancer (P > 0.05). However, there were significant differences (P < 0.01) between all the groups in terms of radiodensities of masses detected by enhanced CT. CONCLUSIONS: The radiodensities of lung masses detected by enhanced CT could potentially be used to differentiate between lung cancer, pulmonary TB and inflammatory lung pseudotumors.